KalVista Pharmaceuticals Earning Date (KALV)

USA |NASDAQ |USD

KALV Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Jul 11, 2022 Apr 2022 $-0.97 $-0.92 $-0.67
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Jul 11, 2022 Apr 2022 $0.00 $0.00 $0.00

Kalvista Pharmaceuticals's next earnings date is Monday, Jul 11, 2022 for the fiscal quarter ending Apr 2022.

KALV Earnings Date & History Chart

KALV Earnings & Revenue Forecast

KALV Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Apr 2023 7 $-3.75 $-4.44 $-2.69

KALV Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Apr 2023 1 / 0 $-3.75 $-3.66 $-3.66

KALV Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Apr 2023 6 $7.72M $0.00 $28.60M

KALV Earnings Date & Revenue History

KALV Earnings History

|
Show More
Show More

KALV Revenue History

|
Show More
Show More

Kalvista Pharmaceuticals Next Earnings Date & Report

KALV Next Earnings Date & Report Preview: Apr 2022 (FQ)

KALV's next earnings date is Monday, Jul 11, 2022 for the fiscal quarter ending Apr 30, 2022.

According to analysts, the average EPS estimation for Kalvista Pharmaceuticals's next quarterly earnings is $-0.97, with a low EPS estimation of $-1.19, and a high estimation of $-0.80.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.97, the last 2 month trend is $-0.90, and the 3 month trend is $-0.90.

Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Kalvista Pharmaceuticals Previous Earnings Dates & Reports

KALV Previous Earnings Date & Report Recap: Jan 2022 (FQ)

Kalvista Pharmaceuticals's previous earnings date was Mar 10, 2022 for its fiscal quarter ended Jan 31, 2022.

KALV's earnings per share (EPS) was $-0.92, beating the consensus analysts forecast of $-0.93 by 1.08%.

The EPS was lower than the previous fiscal quarter (Oct 2021) by 15.00%, and lower than the same period a year before (Jan 2021) by 64.29%.

Revenues were $0.00.

The company reported a net income of $-22.47M.

Free cash flow for the quarter was $-14.27M , compared to $-19.90M last quarter and $-7.60M a year before.

KALV Previous Earnings Date & Report Recap: Apr 2021 (FY)

Kalvista Pharmaceuticals's previous annual earnings date was Jul 13, 2021 for its fiscal year ended Apr 30, 2021.

KALV's earnings per share (EPS) was $-2.42, missing the consensus analysts forecast of $-2.30 by 5.22% , and lower than the previous year's EPS (Apr 2020) by 47.56%.

Revenues were $0.00.

The company reported a net income of $-46.24M.

Kalvista Pharmaceuticals reported a free cash flow of $-30.25M for its fiscal year, compared to $-45.04M a year ago.

The company ended the fiscal year with $5.91M in total debt, an increase of 259.21% compared to the previous year.